易普利姆玛
医学
无容量
黑色素瘤
肿瘤科
内科学
脑转移
队列
免疫疗法
程序性细胞死亡1
总体生存率
PD-L1
癌症
转移
癌症研究
作者
Sarah E. Lochrin,Hannah L. Kalvin,James W. Smithy,Monica F. Chen,Parisa Momtaz,Alexander N. Shoushtari,Katherine S. Panageas,Michael A. Postow
标识
DOI:10.1001/jamaoncol.2024.6168
摘要
This cohort study examines the response and survival rates associated with ipilimumab-nivolumab therapy in patients with progressive melanoma brain metastases after anti–programmed cell death 1 (anti–PD-1) therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI